申请人:Chugai Seiyaku
Kabushiki Kaisha
公开号:EP0565732A1
公开(公告)日:1993-10-20
A compound represented by general formula (I) and a salt thereof, wherein R₁ represents adamanthyl; R₂ represents hydrogen, lower alkyl, lower alkenyl or aralkyl; R₃ represents a 1,4-benzodioxane ring optionally substituted by C₁ to C₄ lower alkyl, lower alkoxy, halogen, amino, hydroxyl or lower alkylcarbonyl. They are excellent in both antidepressant and antianxiety effects and have a reduced toxicity, and hence are useful for preventing and treating neurosis, psychosomatic disorder, autonomic imbalance, depression, and so forth.
通式(I)代表的化合物及其盐,其中R₁代表金刚烷基;R₂代表氢、低级烷基、低级烯基或芳烷基;R₃代表任选被C₁至C₄低级烷基、低级烷氧基、卤素、氨基、羟基或低级烷基羰基取代的1,4-苯并二恶烷环。它们具有良好的抗抑郁和抗焦虑作用,毒性较低,因此可用于预防和治疗神经衰弱、心身疾病、自律神经失调、抑郁症等。